Therefore, it can be speculated that in PCOS patients with a BMI ≥ 27 kg/m2, the heightened risk of vitamin D deficiency associated with metformin use could outweigh the stimulatory effects of androgens, leading to a reduction in osteocalcin levels without compromising BMD. This evidence concerns the gene BGLAP and polycystic ovary syndrome.